 |
|
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song
Clin Mol Hepatol. 2022;28(2):219-231. Published online 2021 Jul 20 DOI: https://doi.org/10.3350/cmh.2021.0082
|
|
Citations to this article as recorded by
 Sarcopenia is associated with new-onset acute biliary infection within 1 year in patients with hepatitis B virus-related decompensated cirrhosis
Shuangshuang Zhang, Tian Zhou, Mingbo Wu, Xuanxuan Xiong
European Journal of Gastroenterology & Hepatology.2025; 37(1): 100. CrossRef Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct‐acting antivirals
Tomoyuki Suehiro, Hideko Kozuru, Kosuke Matusmoto, Yuki Kugiyama, Yasuhide Motoyoshi, Akira Saeki, Shinya Nagaoka, Kazumi Yamasaki, Atsumasa Komori, Hiroshi Yatsuhashi
Hepatology Research.2025;[Epub] CrossRef Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States
Fan Zhang, Longgen Liu, Wenjian Li
Nutrition Journal.2025;[Epub] CrossRef Nutritional screening and assessment tools for patients with cirrhosis based on the Global Leadership Initiative on Malnutrition criteria
Yumei He, Ling Hu, Shiyan Wu, Lu Li, Ke Zhong, Jiazhen Li, Na Liu, Xiaobin Sun, Qiong Wang, Chao Sun, Liping Wu
Journal of Human Nutrition and Dietetics.2024; 37(2): 430. CrossRef Screening and assessment of malnutrition in patients with liver cirrhosis
Yumei He, Zhiming Wang, Shiyan Wu, Lu Li, Jiazhen Li, Yexing Zhang, Boshi Chen, Xiaobin Sun, Chao Sun, Liping Wu
Frontiers in Nutrition.2024;[Epub] CrossRef Bibliometrics and knowledge mapping of the pathogenesis of hepatic encephalopathy in patients with liver cirrhosis
Shiyan Wu, Lu Li, Heng Xi, Xiaoping Wu, Yumei He, Xiaobin Sun, Liping Wu
Heliyon.2024; 10(15): e34330. CrossRef Unraveling the mechanisms of hepatogenous diabetes and its therapeutic perspectives
Manisha Yadav, Smriti Verma, Purnima Tiwari, Madhav Nilakanth Mugale
Life Sciences.2024; 353: 122934. CrossRef New nomenclature and subclassification of steatotic liver disease and loss of skeletal muscle mass: A longitudinal cohort study
Aryoung Kim, Danbee Kang, Sung Chul Choi, Dong Hyun Sinn, Geum‐Youn Gwak
Hepatology Research.2024;[Epub] CrossRef The Interplay Between Depression, Probiotics, Diet, Immunometabolic Health, the Gut, and the Liver—A Secondary Analysis of the Pro-Demet Randomized Clinical Trial
Oliwia Gawlik-Kotelnicka, Jakub Rogalski, Karolina H. Czarnecka-Chrebelska, Jacek Burzyński, Paulina Jakubowska, Anna Skowrońska, Dominik Strzelecki
Nutrients.2024; 16(23): 4024. CrossRef Effects of Alnus japonica Hot Water Extract and Oregonin on Muscle Loss and Muscle Atrophy in C2C12 Murine Skeletal Muscle Cells
Da Hyeon An, Chan Ho Lee, Yeeun Kwon, Tae Hee Kim, Eun Ji Kim, Jae In Jung, Sangil Min, Eun Ju Cheong, Sohyun Kim, Hee Kyu Kim, Sun Eun Choi
Pharmaceuticals.2024; 17(12): 1661. CrossRef Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
Do Seon Song, U Im Chang, Jin Mo Yang
Clinical and Molecular Hepatology.2023; 29(1): 165. CrossRef Interaction between sarcopenia and nonalcoholic fatty liver disease
Sae Kyung Joo, Won Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S68. CrossRef Sarcopenia in cirrhosis: epidemiology, diagnosis, management and prognosis
Yi Liu, Fanpu Ji, Mindie H. Nguyen
Current Opinion in Gastroenterology.2023; 39(3): 131. CrossRef Sinapic Acid Attenuate Liver Injury by Modulating Antioxidant Activity and Inflammatory Cytokines in Thioacetamide-Induced Liver Cirrhosis in Rats
Ahmed A. J. Jabbar, Zaenah Zuhair Alamri, Mahmood Ameen Abdulla, Ahmed S. AlRashdi, Soran Kayfi Najmaldin, Mustafa AbdulMonam Zainel
Biomedicines.2023; 11(5): 1447. CrossRef The Accuracy of Ultrasound Controlled Attenuation Parameter in Diagnosing Hepatic Fat Content
Sebastiana Atzori, Yasmin Pasha, James B Maurice, Simon D Taylor-Robinson, Louise Campbell, Adrian KP Lim
Hepatic Medicine: Evidence and Research.2023; Volume 15: 51. CrossRef Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin
World Journal of Gastroenterology.2023; 29(27): 4236. CrossRef Skeletal muscle fibre morphology in childhood—insights into myopenia in pediatric liver disease
Amber Hager, Vera Mazurak, Michelle Noga, Susan M. Gilmour, Diana R. Mager
Applied Physiology, Nutrition, and Metabolism.2023; 48(10): 730. CrossRef What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?
Katarzyna Ferenc, Sara Jarmakiewicz-Czaja, Rafał Filip
Life.2023; 14(1): 37. CrossRef Hematological and biochemical investigations on the effect of curcumin and Thymoquinone in male mice exposed to Thioacetamide
Atef M. Al-Attar
Saudi Journal of Biological Sciences.2022; 29(1): 660. CrossRef A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction
Myung-Rae Cho, Sungho Lee, Suk-Kyoon Song
Journal of Korean Medical Science.2022;[Epub] CrossRef Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
Takumi Kawaguchi, Takuji Torimura
Clinical and Molecular Hepatology.2022; 28(2): 177. CrossRef
|